SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Investors ▸ Share holder services ▸ Tax on Dividend Information
Communication to shareholders on Final Dividend
Annexure 1 – Declaration from resident shareholders
Annexure 2- Form No 15G
Annexure 3 – Form No 15H
Annexure 4 – Declaration from non-resident shareholders
Annexure 5 -Form 10F
Annexure 6 – Declaration from Non Resident not having PAN
Annexure 7 – Declaration for deduction of TDS in the name of other person
© 2024. Syngene International Limited